DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

Medivation, Inc.


58.10 2.33 (4.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MDVN $58.10 4.18%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.85
Previous Close $55.77
Daily Range $55.46 - $58.30
52-Week Range $44.51 - $88.20
Market Cap $4.4B
P/E Ratio -97.84
Dividend (Yield) $0.00 (0.0%)
Volume 1,932,037
Average Daily Volume 1,266,803
Current FY EPS $0.79





Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website:

News & Commentary

10 States Where Cancer Incidence Is the Highest

According to the CDC, these 10 states have the highest age-adjusted cancer incidence rates. Find out what some of the biggest risk factors are in these states as well as what therapies are being introduced to curb the rising tide of cancer diagnoses.

Strong Rebound for Healthcare Stocks Tuesday; Medivation, UCLA In Legal Fight Over Royalty Payments

Sector Update: Healthcare

Medivation (MDVN) Marked As A Dead Cat Bounce Stock

Credit Suisse Says Grit Your Teeth and Buy Biotech

Bayer Initiates Xofigo Combination Study - Analyst Blog

Stocks To Watch For April 1, 2014

Medivation Breaks Below 200-Day Moving Average - Notable for MDVN

Disappointment Over Prostate Cancer Drug Study Weigh Heavily on Exelixis

Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

Short Sellers Find Renewed Interest in Biotech Stocks

See More MDVN News...

MDVN's Top Competitors

MDVN $58.10 (4.18%)
Current stock: MDVN
TMO $117.65 (1.07%)
Current stock: TMO
ILMN $131.05 (-0.67%)
Current stock: ILMN
WAT $109.65 (0.47%)
Current stock: WAT